Table of Content
1 Industrial Chain Overview
1.1 Nanopharmaceuticals Industry
1.1.1 Overview
Figure Nanopharmaceuticals Picture List
1.1.2 Characteristics of Nanopharmaceuticals
1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview
1.3 Product List By Type
1.3.1 Liposomes
1.3.2 Polymeric Micelles
1.3.3 Solid Lipid Nanoparticles
1.3.4 Microemulsion And Nanoemulsion
1.3.5 Nanosuspension
1.4 End-Use List
1.4.1 Demand in Cancer
1.4.2 Demand in Tumor
1.4.3 Demand in Autoimmune Disorders
1.5 Global Market Overview
1.5.1 Global Market Size and Forecast, 2017-2027
Figure Global Market Size and Forecast with Growth Rate, 2017-2027
1.5.2 Global Market Size and Forecast by Geography with CAGR, 2017-2027
Table Global Market Size and Forecast by Geography with Growth Rate, 2017-2027
1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2017-2027
Table Global Market Size and Forecast by Type with Growth Rate, 2017-2027
1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2017-2027
Table Global Market Size and Forecast by End-Use with Growth Rate, 2017-2027
2 Global Production & Consumption by Geography
2.1 Global Production & Consumption
2.1.1 Global Production
Figure Global Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Global Production Volume Status and Growth Rate by Geography, 2017-2021, in Volume
Figure Global Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Global Production Amount Status and Growth Rate by Geography, 2017-2021, in Million USD
2.1.2 Global Consumption
Figure Global Market Volume and Growth Rate, 2017-2021, in Volume
Table Global Market Volume and Growth Rate by Geography, 2017-2021, in Volume
Figure Global Market Amount and Growth Rate, 2017-2021, in Million USD
Table Global Market Amount and Growth Rate by Geography, 2017-2021, in Million USD
2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
Figure Asia-Pacific Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.2 North America
Figure North America Production Volume Status and Growth Rate, 2017-2021, in Volume
Table North America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure North America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table North America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.3 South America
Figure South America Production Volume Status and Growth Rate, 2017-2021, in Volume
Table South America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure South America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table South America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.4 Europe
Figure Europe Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Europe Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure Europe Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Europe Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.5 Middle East & Africa
Figure Middle East & Africa Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure Middle East & Africa Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.2 Consumption
2.2.2.1 Asia-Pacific
Figure Asia-Pacific Market Volume and Growth Rate, 2017-2021, in Volume
Table Asia-Pacific Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure Asia-Pacific Market Amount and Growth Rate, 2017-2021, in Million USD
Table Asia-Pacific Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.2 North America
Figure North America Market Volume and Growth Rate, 2017-2021, in Volume
Table North America Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure North America Market Amount and Growth Rate, 2017-2021, in Million USD
Table North America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.3 South America
Figure South America Market Volume and Growth Rate, 2017-2021, in Volume
Table South America Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure South America Market Amount and Growth Rate, 2017-2021, in Million USD
Table South America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.4 Europe
Figure Europe Market Volume and Growth Rate, 2017-2021, in Volume
Table Europe Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure Europe Market Amount and Growth Rate, 2017-2021, in Million USD
Table Europe Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.5 Middle East & Africa
Figure Middle East & Africa Market Volume and Growth Rate, 2017-2021, in Volume
Table Middle East & Africa Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure Middle East & Africa Market Amount and Growth Rate, 2017-2021, in Million USD
Table Middle East & Africa Market Amount and Growth Rate by Region, 2017-2021, in Million USD
3 Major Manufacturers Introduction
3.1 Manufacturers Overview
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2021
3.2 Manufacturers List
3.2.1 Merck Overview
Table Merck Overview List
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Nanopharmaceuticals Business Operation of Merck (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 Pfizer Overview
Table Pfizer Overview List
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Nanopharmaceuticals Business Operation of Pfizer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 Novartis Overview
Table Novartis Overview List
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Nanopharmaceuticals Business Operation of Novartis (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 Abbott Overview
Table Abbott Overview List
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Nanopharmaceuticals Business Operation of Abbott (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 GlaxoSmithKline Overview
Table GlaxoSmithKline Overview List
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Nanopharmaceuticals Business Operation of GlaxoSmithKline (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 Roche Overview
Table Roche Overview List
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Nanopharmaceuticals Business Operation of Roche (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 Sanofi Overview
Table Sanofi Overview List
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Nanopharmaceuticals Business Operation of Sanofi (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
3.2.8 Eli Lilly Overview
Table Eli Lilly Overview List
3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Nanopharmaceuticals Business Operation of Eli Lilly (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning
3.2.9 Astrazeneca Overview
Table Astrazeneca Overview List
3.2.9.1 Product Specifications
3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Nanopharmaceuticals Business Operation of Astrazeneca (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.9.3 Recent Developments
3.2.9.4 Future Strategic Planning
3.2.10 Johnson & Johnson Overview
Table Johnson & Johnson Overview List
3.2.10.1 Product Specifications
3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Nanopharmaceuticals Business Operation of Johnson & Johnson (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.10.3 Recent Developments
3.2.10.4 Future Strategic Planning
3.2.11 Celgene Overview
Table Celgene Overview List
3.2.11.1 Product Specifications
3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Nanopharmaceuticals Business Operation of Celgene (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.11.3 Recent Developments
3.2.11.4 Future Strategic Planning
3.2.12 Novavax Overview
Table Novavax Overview List
3.2.12.1 Product Specifications
3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Nanopharmaceuticals Business Operation of Novavax (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.12.3 Recent Developments
3.2.12.4 Future Strategic Planning
3.2.13 Stryker Overview
Table Stryker Overview List
3.2.13.1 Product Specifications
3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Nanopharmaceuticals Business Operation of Stryker (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.13.3 Recent Developments
3.2.13.4 Future Strategic Planning
3.2.14 Gilead Sciences Overview
Table Gilead Sciences Overview List
3.2.14.1 Product Specifications
3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Nanopharmaceuticals Business Operation of Gilead Sciences (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.14.3 Recent Developments
3.2.14.4 Future Strategic Planning
3.2.15 OSI Pharmaceuticals Overview
Table OSI Pharmaceuticals Overview List
3.2.15.1 Product Specifications
3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Nanopharmaceuticals Business Operation of OSI Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.15.3 Recent Developments
3.2.15.4 Future Strategic Planning
3.2.16 Kadmon Pharmaceuticals Overview
Table Kadmon Pharmaceuticals Overview List
3.2.16.1 Product Specifications
3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Nanopharmaceuticals Business Operation of Kadmon Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.16.3 Recent Developments
3.2.16.4 Future Strategic Planning
3.2.17 Samyang Biopharm Overview
Table Samyang Biopharm Overview List
3.2.17.1 Product Specifications
3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Nanopharmaceuticals Business Operation of Samyang Biopharm (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.17.3 Recent Developments
3.2.17.4 Future Strategic Planning
3.2.18 Mitsubishi Pharma Overview
Table Mitsubishi Pharma Overview List
3.2.18.1 Product Specifications
3.2.18.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Nanopharmaceuticals Business Operation of Mitsubishi Pharma (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.18.3 Recent Developments
3.2.18.4 Future Strategic Planning
3.2.19 Kaken Pharmaceutical Overview
Table Kaken Pharmaceutical Overview List
3.2.19.1 Product Specifications
3.2.19.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Nanopharmaceuticals Business Operation of Kaken Pharmaceutical (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.19.3 Recent Developments
3.2.19.4 Future Strategic Planning
3.2.20 Selecta Biosciences Overview
Table Selecta Biosciences Overview List
3.2.20.1 Product Specifications
3.2.20.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Nanopharmaceuticals Business Operation of Selecta Biosciences (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.20.3 Recent Developments
3.2.20.4 Future Strategic Planning
3.2.21 Par Pharmaceutical Overview
Table Par Pharmaceutical Overview List
3.2.21.1 Product Specifications
3.2.21.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Nanopharmaceuticals Business Operation of Par Pharmaceutical (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.21.3 Recent Developments
3.2.21.4 Future Strategic Planning
3.2.22 Cerulean Pharma Overview
Table Cerulean Pharma Overview List
3.2.22.1 Product Specifications
3.2.22.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Nanopharmaceuticals Business Operation of Cerulean Pharma (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.22.3 Recent Developments
3.2.22.4 Future Strategic Planning
3.2.23 Navidea Biopharmaceuticals Overview
Table Navidea Biopharmaceuticals Overview List
3.2.23.1 Product Specifications
3.2.23.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Nanopharmaceuticals Business Operation of Navidea Biopharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.23.3 Recent Developments
3.2.23.4 Future Strategic Planning
3.2.24 Lummy Overview
Table Lummy Overview List
3.2.24.1 Product Specifications
3.2.24.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Nanopharmaceuticals Business Operation of Lummy (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.24.3 Recent Developments
3.2.24.4 Future Strategic Planning
4 Market Competition Pattern
4.1 Market Size and Sketch
Figure Global Market Size and Growth Rate, 2017-2021, in Volume
Figure Global Market Size and Growth Rate, 2017-2021, in Million USD
Figure Global Competition Sketch Overview
4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
Table Global Production Volume List by Manufacturers, 2017-2021, in Volume
Table Global Production Volume Share List by Manufacturers, 2017-2021, in Volume
Figure Global Production Volume Share by Manufacturers in 2021, in Volume
Table Global Production Amount List by Manufacturers, 2017-2021, in Million USD
Table Global Production Amount Share List by Manufacturers, 2017-2021, in Million USD
Figure Global Production Amount Share by Manufacturers in 2021, in Million USD
4.2.2 Market Concentration Analysis
4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 Product Type Segment
5.1 Global Overview by Product Type Segment
Table Global Market Status and Growth Rate by Product Type Segment, 2017-2021, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2017-2021, in Volume
5.2 Segment Subdivision by Product Type
5.2.1 Market in Liposomes
5.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Liposomes, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Liposomes, 2017-2021, in Volume
5.2.1.2 Situation & Development
5.2.2 Market in Polymeric Micelles
5.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Polymeric Micelles, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Polymeric Micelles, 2017-2021, in Volume
5.2.2.2 Situation & Development
5.2.3 Market in Solid Lipid Nanoparticles
5.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Solid Lipid Nanoparticles, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Solid Lipid Nanoparticles, 2017-2021, in Volume
5.2.3.2 Situation & Development
5.2.4 Market in Microemulsion And Nanoemulsion
5.2.4.1 Market Size
Figure Global Market Amount and Growth Rate in Microemulsion And Nanoemulsion, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Microemulsion And Nanoemulsion, 2017-2021, in Volume
5.2.4.2 Situation & Development
5.2.5 Market in Nanosuspension
5.2.5.1 Market Size
Figure Global Market Amount and Growth Rate in Nanosuspension, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Nanosuspension, 2017-2021, in Volume
5.2.5.2 Situation & Development
6 End-Use Segment
6.1 Global Overview by End-Use Segment
Table Global Market Status and Growth Rate by End-Use Segment, 2017-2021, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2017-2021, in Volume
6.2 Segment Subdivision
6.2.1 Market in Cancer
6.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Cancer, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Cancer, 2017-2021, in Volume
6.2.1.2 Situation & Development
6.2.2 Market in Tumor
6.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Tumor, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Tumor, 2017-2021, in Volume
6.2.2.2 Situation & Development
6.2.3 Market in Autoimmune Disorders
6.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Autoimmune Disorders, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Autoimmune Disorders, 2017-2021, in Volume
6.2.3.2 Situation & Development
7 Market Forecast & Trend
7.1 Regional Forecast
Table Global Market Forecast by Region Segment 2022-2027, in Million USD
Table Global Market Forecast by Region Segment 2022-2027, in Volume
7.2 Consumption Forecast
7.2.1 Product Type Forecast
Table Global Market Amount by Product Type Segment 2022-2027, in Million USD
Table Global Market Volume by Product Type Segment 2022-2027, in Volume
7.2.2 End-Use Forecast
Table Global Market Amount by End-Use Segment 2022-2027, in Million USD
Table Global Market Volume by End-Use Segment 2022-2027, in Volume
7.3 Investment Trend
7.4 Consumption Trend
8 Price & Channel
8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
Figure Cost Component Ratio
8.2 Channel Segment
9 Market Drivers & Investment Environment
9.1 Market Drivers
9.2 Investment Environment
9.3 Impact of Coronavirus on the Nanopharmaceuticals Industry
9.3.1 Impact on Industry Upstream
9.3.2 Impact on Industry Downstream
9.3.3 Impact on Industry Channels
9.3.4 Impact on Industry Competition
9.3.5 Impact on Industry Employment
10 Research Conclusion